Literature DB >> 20629151

Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.

Daniela Berg1, Klaus Seppi, Inga Liepelt, Katherine Schweitzer, Frank Wollenweber, Björn Wolf, Ulrich Dillmann, Heike Stockner, Jana Godau, Stefan Kiechl, Alexandra Gaenslen, Johann Willeit, Adriana Di Santo, Walter Maetzler, Thomas Gasser, Werner Poewe, Stefanie Behnke.   

Abstract

Enlarged substantia nigra hyperechogenicity (SN+) assessed by transcranial sonography (TCS) may be associated with Parkinson's disease (PD) risk markers such as impaired motor performance and hyposmia. The aim of this multicenter cross-sectional study was to define the association between SN+ and these risk markers in a large population older than 50 years without the diagnosis of PD. In three centers (Tuebingen, Homburg, and Innsbruck), 1,839 individuals were examined. The echostatus of the SN was assessed by TCS, motor performance by the Unified Parkinson's Disease Rating Scale (UPDRS) motor score, and olfactory function with Sniffin' Sticks. From the 1,603 subjects included in the analysis, 16.2% were SN+, 23.0% scored above zero in the UPDRS motor section, and 28.0% were hyposmic as defined by less than 75% correctly classified Sniffin' Sticks. SN+ was associated with a UPDRS motor score above zero (OR 1.45, 95% CI 1.08-1.96) and with a lower odor identification capability (OR 1.48, 95% CI 1.12-1.96). The combination of these two features (OR 1.98, 95% CI 1.25-3.15) and UPDRS motor scores >or=3 lead to higher OR. It is concluded that SN+, impaired motor performance, and hyposmia are frequently observed in the elderly and in isolation are unspecific and of limited use to predict a subject's risk for PD. Whether the association of SN+ with both impaired motor performance and hyposmia as seen in this study predicts an increased risk for the development of PD needs to be evaluated in the follow-up investigations. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20629151     DOI: 10.1002/mds.23114

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

Review 1.  [Early recognition of Parkinson's disease. Objectifiable non-motor symptoms and biomarkers].

Authors:  B Mollenhauer; F Sixel-Döring; A Storch; C Schneider; R Hilker; E Kalbe
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

Review 2.  Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.

Authors:  Andrea Pilotto; Rezzak Yilmaz; Daniela Berg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

3.  Relation of risk factors and putative premotor markers for Parkinson's disease.

Authors:  I Liepelt-Scarfone; S Behnke; J Godau; K J Schweitzer; B Wolf; A Gaenslen; D Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-06       Impact factor: 3.575

4.  Risk factors and prodromal markers and the development of Parkinson's disease.

Authors:  Stefanie Lerche; Klaus Seppi; Stefanie Behnke; Inga Liepelt-Scarfone; Jana Godau; Philipp Mahlknecht; Alexandra Gaenslen; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Heike Stockner; Stefan Kiechl; Johann Willeit; Arno Gasperi; Klaus Fassbender; Werner Poewe; Daniela Berg
Journal:  J Neurol       Date:  2013-11-05       Impact factor: 4.849

5.  Autonomic dysfunction in subjects at high risk for Parkinson's disease.

Authors:  Inga Liepelt-Scarfone; Andrea Pilotto; Katharina Müller; Christian Bormann; Katharina Gauss; Isabel Wurster; Johannes Streffer; Daniela Berg
Journal:  J Neurol       Date:  2015-11-03       Impact factor: 4.849

6.  Impaired trunk stability in individuals at high risk for Parkinson's disease.

Authors:  Walter Maetzler; Martina Mancini; Inga Liepelt-Scarfone; Katharina Müller; Clemens Becker; Rob C van Lummel; Erik Ainsworth; Markus Hobert; Johannes Streffer; Daniela Berg; Lorenzo Chiari
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

Review 7.  Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease.

Authors:  Marina Picillo; Paolo Barone; Maria Teresa Pellecchia
Journal:  Mov Disord Clin Pract       Date:  2017-08-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.